Bristol-Myers Squibb (BMY) Reports In-Line Q2 EPS, Updates FY EPS Guidance
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $63.06 +0.35%
Revenue Growth %: +3.2%
Financial Fact:
Cost of products sold: 1.31B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +3.2%
Financial Fact:
Cost of products sold: 1.31B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $0.74, in-line with the analyst estimate of $0.74. Revenue for the quarter came in at $5.14 billion versus the consensus estimate of $5.09 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2017 EPS of $2.90-$3.00, versus the consensus of $2.95.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb Co. (BMY) PT Raised to $82 at Piper Sandler
- Corpay agrees to $100M FTC settlement over marketing practices
- Westinghouse said to seek over $50 billion valuation in planned IPO
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
